Helus Pharma is a biopharmaceutical company that develops psychedelic therapeutics for mental health conditions.
Helus Pharma has raised $50.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in September 2026.
Helus Pharma's investors include RA Capital Management, Point72, Janus Henderson Investors, OrbiMed, Adage Capital Management.
Helus Pharma is headquartered in Toronto, Canada.
Helus Pharma is a biopharmaceutical company that develops psychedelic therapeutics for mental health conditions.
Helus Pharma is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Helus Pharma — Funding & Investors." VCBacked, September 9, 2026, https://www.vcbacked.co/company/helus-pharma. Accessed November 13, 2026.
VCBacked. (2026). Helus Pharma — Funding & Investors. Retrieved November 13, 2026, from https://www.vcbacked.co/company/helus-pharma
{{cite web |title=Helus Pharma — Funding & Investors |url=https://www.vcbacked.co/company/helus-pharma |website=VCBacked |access-date=November 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Helus Pharma? Request a listing update